The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa.

HIV incidence HIV stigma PLHIV cluster randomized trial community members health workers

Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
07 2022
Historique:
received: 19 10 2021
accepted: 03 05 2022
entrez: 12 7 2022
pubmed: 13 7 2022
medline: 14 7 2022
Statut: ppublish

Résumé

To investigate the association between individual and community-level measures of HIV stigma and HIV incidence within the 21 communities participating in the HPTN (071) PopART trial in Zambia and South Africa. Secondary analysis of data from a population-based cohort followed-up over 36 months between 2013 and 2018. The outcome was rate of incident HIV infection among individuals who were HIV negative at cohort entry. Individual-level exposures, measured in a random sample of all participants, were: (1) perception of stigma in the community, (2) perception of stigma in health settings and (3) fear and judgement towards people living with HIV. Individual-level analyses were conducted with adjusted, individual-level Poisson regression. Community-level HIV stigma exposures drew on data reported by people living with HIV, health workers and community members. We used linear regression to explore the association between HIV stigma and community-level HIV incidence. Among 8172 individuals who were HIV negative and answered individual-level stigma questions at enrolment to the cohort, there was no evidence of a statistically significant association between any domain of HIV stigma and risk of incident HIV infection. Among the full cohort of 26,110 individuals among whom HIV incidence was measured, there was no evidence that community-level HIV incidence was associated with any domain of HIV stigma. HIV stigma is often cited as a barrier to the effectiveness of HIV prevention programming. However, in the setting for the HPTN 071 "PopART trial," measured stigma alone was not associated with the risk of HIV infection.

Identifiants

pubmed: 35818869
doi: 10.1002/jia2.25931
pmc: PMC9274206
doi:

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25931

Subventions

Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : UM1 AI068613
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068617
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069521
Pays : United States

Informations de copyright

© 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

N Engl J Med. 2019 Jul 18;381(3):207-218
pubmed: 31314965
Lancet HIV. 2016 Jul;3(7):e318-22
pubmed: 27365206
J Int AIDS Soc. 2019 Sep;22(9):e25391
pubmed: 31536171
J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):561-570
pubmed: 32991336
J Int AIDS Soc. 2019 Dec;22(12):e25421
pubmed: 31840400
Ann Behav Med. 2012 Jun;43(3):362-71
pubmed: 22367752
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):399-407
pubmed: 28406807
Trials. 2014 Feb 13;15:57
pubmed: 24524229
Am J Public Health. 2017 Jun;107(6):863-869
pubmed: 28426316
Health Policy Plan. 2021 Jun 25;36(6):881-890
pubmed: 33963387
BMC Med. 2019 Feb 15;17(1):7
pubmed: 30764816
AIDS Patient Care STDS. 2020 Jan;34(1):38-50
pubmed: 31944852
PLoS One. 2022 Feb 22;17(2):e0264249
pubmed: 35192663
AIDS. 2020 Nov 15;34(14):2125-2135
pubmed: 32773484
Soc Sci Med. 2018 Sep;213:72-84
pubmed: 30059900
AIDS Patient Care STDS. 2006 Feb;20(2):133-42
pubmed: 16475894
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):46-53
pubmed: 29847480
AIDS Behav. 2017 Jan;21(1):300-306
pubmed: 27351194
AIDS Care. 2016;28 Suppl 3:1-6
pubmed: 27421046
AIDS Res Ther. 2021 Jan 6;18(1):1
pubmed: 33407664
Ann Epidemiol. 2018 Jan;28(1):13-19
pubmed: 29425532
AIDS Behav. 2013 Sep;17(7):2528-39
pubmed: 23474643
J Int AIDS Soc. 2020 Mar;23(3):e25463
pubmed: 32144874
AIDS Educ Prev. 2005 Feb;17(1):1-11
pubmed: 15843106
BMC Public Health. 2013 Mar 11;13:220
pubmed: 23497196
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18640
pubmed: 24242258
AIDS Patient Care STDS. 2020 Jan;34(1):7-15
pubmed: 31944853
Health Policy Plan. 2016 Dec;31(10):1342-1354
pubmed: 27375126
Int J STD AIDS. 2021 Aug;32(9):791-798
pubmed: 33769905
Afr J AIDS Res. 2019 Mar;18(1):27-37
pubmed: 30782082
AIDS. 2008 Aug;22 Suppl 2:S67-79
pubmed: 18641472

Auteurs

James R Hargreaves (JR)

Department of Public Health, Environments and Society, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Triantafyllos Pliakas (T)

Department of Public Health, Environments and Society, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Graeme Hoddinott (G)

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Tila Mainga (T)

Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.

Constance Mubekapi-Musadaidzwa (C)

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Deborah Donnell (D)

Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Ethan Wilson (E)

Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Estelle Piwowar-Manning (E)

Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.

Yaw Agyei (Y)

Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.

Nomtha F Bell-Mandla (NF)

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Rory Dunbar (R)

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Ab Schaap (A)

Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.

David Macleod (D)

Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Sian Floyd (S)

Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Peter Bock (P)

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Sarah Fidler (S)

Department of Medicine, Imperial College NIHR BRC, Imperial College London, London, UK.

Janet Seeley (J)

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Anne Stangl (A)

International Center for Research on Women, Washington, DC, USA.
Hera Solutions, Baltimore, Maryland, USA.

Virginia Bond (V)

Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.
Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Helen Ayles (H)

Zambart, School of Public Health, University of Zambia, Lusaka, Zambia.
Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Richard J Hayes (RJ)

Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH